AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TEICOPLANIN
20 registrations across 2 African markets— 15 active
Markets with TEICOPLANIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TEICOPLANIN MYLAN POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED (STERILE PRODUCT DIVISION) | active | Dec 2027 |
| TEIKOPOL 200MG POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | WMT PHARMACEUTICALS | active | Dec 2027 |
| TEIKOPOL 400MG POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | WMT PHARMACEUTICALS | active | Dec 2027 |
| PLANITEC 200 POWDER | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Aug 2025 |
| CIPLA-TEICOPLANIN 200 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| PLANITEC 400 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | suspended | Sept 2023 |
| SPEC TEICOPLANIN 400 | 🇿🇦South Africa | Specpharm (Pty) Ltd | suspended | Nov 2022 |
| SPEC TEICOPLANIN 200 | 🇿🇦South Africa | Specpharm (Pty) Ltd | suspended | Nov 2022 |
| TEGORID IV 200 | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| SANDOZ TEICOPLANIN 200 POWDER | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| TEICOWIN 200 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | active | Jan 1900 |
| TEICOWIN 400 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | active | Jan 1900 |
| CIPLA-TEICOPLANIN 400 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 1900 |
| TEICOPLANIN 200 mg PD | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Jan 1900 |
| TEICOPLANIN ENDO 200 | 🇿🇦South Africa | ACINO PHARMA (PTY) LTD | active | Jan 1900 |
| TEICOPLANIN ENDO 400 | 🇿🇦South Africa | ACINO PHARMA (PTY) LTD | active | Jan 1900 |
| ASPEN TEICOPLANIN 400 | 🇿🇦South Africa | ACINO PHARMA (PTY) LTD | active | Jan 1900 |
| TEGORIDIV 400 | 🇿🇦South Africa | Austell Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| ASPEN TEICOPLANIN 200 | 🇿🇦South Africa | ACINO PHARMA (PTY) LTD | active | Jan 1900 |
| TEICOPLANIN 400 mg PD | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Jan 1900 |
TEICOPLANIN in Africa — Regulatory Overview
TEICOPLANIN is registered across 2 African markets with 20 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 20 registrations, 15 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.